As a company focused on promoting the advancement of health care in Indonesia, Pfizer has demonstrated a strong commitment to enhancing public health, education, and environmental sustainability. Pfizer’s CSR initiatives are centered around improving healthcare access, developing local talents, and contributing to environmental conservation in Indonesia. One of its cornerstone programs is the HigherHeight – Pfizer Biotech Fellowship, launched in 2021, which is designed to upskill Indonesia's biotech talent pool by providing specialized training to students, researchers, and educators. To date, the program has reached over 104 students and 30 researchers from 18 universities nationwide. In 2023, a select group of lecturers had the opportunity to visit Pfizer’s advanced manufacturing facility in Puurs, Belgium, gaining first-hand experience with global pharmaceutical operations. In parallel, Pfizer Indonesia has been actively involved in continuously training Indonesia’s healthcare workers. In 2024 alone, Pfizer supported the education of 24,864 healthcare professionals, ensuring they are equipped with the latest medical knowledge and skills. Another initiative, Pfizer’s Strengthening Primary Healthcare (SHARE) Project launched in 2020, has empowered around 230 community health workers in Bogor Regency with the skills needed to promote good health practices, facilitate early disease detection, and provide maternal and child health education directly within communities. The company has also made significant strides in community health literacy through the Desa Bijak Antibiotika (SAJAKA) Program. This program, which was launched in 2023 in Bali, focuses on combating the irrational use of antibiotics—a prevalent issue that often leads to antimicrobial resistance. By involving families, healthcare workers, and students in interactive workshops, the program aims to transform perceptions and behaviors surrounding antibiotic use in the community. Additionally, Pfizer Indonesia has shown a deep commitment to environmental sustainability. In October 2023, the company participated in a mangrove tree planting initiative in collaboration with the International Pharmaceutical Manufacturers Group (IPMG) as part of Indonesia’s Net Zero Carbon initiative. This project, which will continue through 2025, aims to plant 3,450 mangrove trees, contributing to the country’s efforts to combat climate change.